On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Why people who use heroin aren't as afraid of deadly fentanyl as they should be
Decades of misinformation from the war on drugs have left hardcore users cynical about a very real danger.
Women speak out: Understanding women who inject drugs in Indonesia
The needs of women who inject drugs have largely been ignored by existing programmes and policies in Indonesia.
New advice on reducing health inequalities in the criminal justice system
Local bodies can use new advice to close the shocking health gap between people in the criminal justice system and the wider population.
Heroin-assisted treatment in Switzerland: successfully regulating the supply and use of a high-risk injectable drug
A number of countries prescribe heroin for use under medical supervision, as part of successful programmes to treat people who use illicit opioids, long-term.
The Seven Costs
The War on Drugs: Are we paying too high a price?
Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims
This study examined health insurance claims among 10,311,961 patients who filled prescriptions for opioids. Specifically, they evaluated how opioid receipt differed among patients with and without a wide range of preexisting psychiatric and behavioural conditions.
Circumstances surrounding non-fatal opioid overdoses attended by ambulance services
This paper explores characteristics associated with non-fatal overdoses and aims to identify possible trends among these events in an urban area in Norway.
The 2016 Hep-CORE Report
Monitoring the implementation of hepatitis B and C policy recommendations in Europe.
Researchers identify factors associated with stopping treatment for opioid dependence
Individuals with opioid dependence who are treated with buprenorphine, a commonly prescribed drug to treat addiction, are more likely to disengage from treatment programs if they are black or Hispanic, unemployed, or have hepatitis C according to a study.
A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA
The authors estimate the economic costs and benefits of establishing a potential SIF in San Francisco using mathematical models that combine local public health data with previous research on the effects of existing SIFs.
Share this on: